Talbot, Julie
Fombonne, Joanna
Torrejon, Jacob
Babcock, Benjamin R. https://orcid.org/0000-0002-2902-8045
McSwain, Leon F.
Rama, Nicolas https://orcid.org/0000-0003-1614-7755
Lospinoso Severini, Ludovica
Bonerandi, Emma
Marsaud, Veronique
Bernardi, Flavia https://orcid.org/0000-0002-9740-2983
Gharsalli, Tarek
Guix, Catherine
Ducarouge, Benjamin https://orcid.org/0000-0002-6701-0508
Neururer, Verena
Basili, Irene https://orcid.org/0000-0002-5117-2529
Mercier, Audrey L.
Yu, Hua https://orcid.org/0009-0001-6923-9111
Forget, Antoine
Indersie, Emilie https://orcid.org/0000-0001-8974-6551
Leboucher, Sophie https://orcid.org/0000-0001-9922-8205
Souphron, Judith
Okonechnikov, Konstantin
Wang, Wanchen https://orcid.org/0000-0002-4098-7482
Kawauchi, Daisuke
Wainwright, Brandon J.
Frappaz, Didier
Varlet, Pascale
Dufour, Christelle https://orcid.org/0000-0001-5993-8077
Beccaria, Kevin
Blauwblomme, Thomas https://orcid.org/0000-0003-4076-9642
Martignetti, Loredana https://orcid.org/0000-0003-1535-7515
Di Marcotullio, Lucia https://orcid.org/0000-0003-0274-7178
Puget, Stéphanie
Doz, François
Bourdeaut, Franck https://orcid.org/0000-0001-9489-6781
Masliah-Planchon, Julien
Gershon, Timothy R. https://orcid.org/0000-0001-7034-6400
Mehlen, Patrick https://orcid.org/0000-0003-1743-5417
Ayrault, Olivier https://orcid.org/0000-0002-7942-6674
Article History
Received: 30 July 2022
Accepted: 29 April 2025
First Online: 3 June 2025
Competing interests
: P.M. declared to have a conflict of interest as shareholder of Netris Pharma. The remaining authors declare no competing interests.